Shares of Cycurion surged as much as 19% in pre-market trading to $3.20 on October 2 after the cybersecurity micro-cap announced Nasdaq had confirmed the company regained compliance with the exchange's $1.00 minimum bid-price rule — a development that removes the immediate threat of delisting but does little to address deeper questions about the firm's fundamentals. Cycurion Dodges Delisting After Its Second Reverse Split in a Year — but Does Survival Equal a Turnaround?
Shares of Cycurion jumped 19% to $3.20 in pre-market trading on October 2 after the micro-cap cybersecurity firm said Nasdaq confirmed it had regained compliance with the exchange's $1.00 minimum bid-price rule. The move removes the most immediate existential risk — forced delisting — but it arrived only through financial engineering, not organic demand for the stock.
• Two Reverse Splits in Ten Months Tell Their Own Story. Cycurion executed a 1-for-30 reverse split on October 27, 2025 , yet shares slid back below $1.00 by mid-2026. Because that split occurred within the prior year, Nasdaq ruled the company ineligible for the standard 180-day grace period and moved toward suspension. A second reverse split — this time 1-for-8 — took effect August 28, 2026 , artificially lifting the price above $1.00 long enough to satisfy the 10-consecutive-day requirement. A combined 1-for-240 shrinkage of the share count in under a year is a red flag, not a catalyst.
• The Revenue Engine Is Still Small and Shrinking. Q2 2026 revenue came in at $3.8 million, down from $3.9 million a year earlier; first-half revenue fell to $7.0 million from $7.8 million . Management blamed a delayed large-contract start . Even if those contracts materialize, this is a company running at roughly a $14 million annual revenue pace while still burning cash — net loss attributable to Cycurion was $5.9 million through just the first half .
• Margin Gains Are Real but Unproven at Scale. Gross margin expanded from 6.1% in Q2 2025 to 29.1% in Q2 2026 — a genuine improvement that management credits to shedding low-margin legacy work. Whether that holds as the company tries to ramp a landmark $54.6 million, 10-year government contract expected to generate over $5 million annually starting in November remains the key test.
• The Backlog Number Looks Big — Relative to Everything Else. Cycurion claims roughly $112 million in contracted backlog , and management projects a $30 million revenue run-rate once new deals ramp. At a $3.20 share price and approximately 3.2 million post-split shares outstanding, the market cap sits near just $10 million — a fraction of the backlog. But backlog is a promise, not revenue; converting it while keeping margins intact and avoiding further dilution is the only math that matters now.